Acne Product

NatMedica, LLC is pleased to team with world-renowned Dr. Lorraine Meisner and Miraderm, Inc as distributor of the new Miraderm® lines of products. The Miraderm® Psoriasis Line provides a unique OTC treatment to Psoriasis, Dermatitis, Eczema and similar skin conditions, without Coal Tar, Steroids or any adverse side effects

(PRWEB) August 16, 2004 -- NatMedica, LLC is pleased to team with world-renowned Dr. Lorraine Meisner and Miraderm, Inc as distributor of the new Miraderm® lines of products. The Miraderm® Psoriasis Line provides a unique OTC treatment to Psoriasis, Dermatitis, Eczema and similar skin conditions, without Coal Tar, Steroids or any adverse side effects.

Dr. Meisner is a leader in the field of cell growth and regulation. Among her patents is the discovery of a vitamin C anti-aging formulation that is the main ingredient for anti-aging products sold globally. She has been a faculty member at the University of Wisconsin-Madison since 1968, and has held prestigious positions at Stanford University and the University of Virginia.

Many have heard of psoriasis, but unfortunately few truly understand the affliction or are familiar with its therapies. Psoriasis is a chronic disease, linked to the immune system. This disease affects about 1-2% of the U.S. population (approximately 5 million people), and although it can occur at any age, it frequently manifests itself between the ages of 15 and 35.

“Frankly, I am quite excited about making this UNIQUE product available to psoriasis patients who have been looking for a safe and effective topical therapy,” said Rob Herrera, President of NatMedica, LLC. “In the case of psoriasis, the cure is many times as bad as the disease and we are happy to market an OTC product with proven results without adverse side effects”.

NatMedica, LLC plans to extend their relationship with Miraderm, Inc. in the upcoming distribution of products to treat Adult Acne and Damaged Skin. The Miraderm® Psoriasis line is currently available and the Adult Acne product will be available on October of 2004.

For product availability and questions about distribution and sales, contact NatMedica at 888-NAT-MEDI (888-628-6334) or e-mail at e-mail protected from spam bots.